Cargando…
PTEN breast cancer susceptibility: a matter of dose
The phosphatase and tensin homolog located on chromosome ten, PTEN, is one of the most commonly mutated tumor suppressor genes (TSGs) in human cancer [1–3]. PTEN catalyzes the conversion of the membrane lipid second messenger PIP3 to PIP2 and is therefore a key mediator of the AKT/PKB pathway [4,5]....
Autor principal: | Alimonti, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234025/ https://www.ncbi.nlm.nih.gov/pubmed/22276040 http://dx.doi.org/10.3332/ecancer.2010.192 |
Ejemplares similares
-
Pten Dose Dictates Cancer Progression in the Prostate
por: Trotman, Lloyd C, et al.
Publicado: (2003) -
Breast dose matters
por: Moadel, Renee M., et al.
Publicado: (2021) -
Dose of PTEN Gene Drives Progression of Prostate Cancer
Publicado: (2003) -
Partial PTEN deletion is linked to poor prognosis in breast cancer
por: Lebok, P., et al.
Publicado: (2015) -
The association of PTEN hypermethylation and breast cancer: a meta-analysis
por: Luo, Shanshan, et al.
Publicado: (2016)